Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using a new device to monitor heart pressure in patients recovering from heart failure

Official title: A Prospective, Observational, Single Centre Study to Assess the Feasibility of the Data Harvested by the Acorai Intracardiac Pressure Monitoring (ICPM) System in Predicting Prognosis in Patients Discharged From Hospital After Treatment for Acute Decompensated Heart Failure

Run by Royal Brompton & Harefield NHS Foundation Trust · NCT06397833 · Data updated 2026-11-12

This study is testing a new device that measures heart pressure in patients recovering from heart failure to see if it can help doctors predict who might get worse and improve their care.

More Heart Failure trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorRoyal Brompton & Harefield NHS Foundation Trust
Academic / other
Drugs / interventionsradiation
Locations1 site (Uxbridge, Middlesex)
StatusRecruiting
StartedApril 29, 2024
Main results expectedFebruary 1, 2026
Study endsFebruary 1, 2027
Registry record updatedApril 8, 2025
Trial IDNCT06397833 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients who are medically fit for discharge after treatment for decompensated heart failure and require intravenous diuretic therapy.

Probably not a fit

Patients who are pregnant or those deemed unsuitable for the study by the investigator may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the Acorai Heart Monitor, a non-invasive device designed to measure intracardiac pressures in patients discharged from the hospital after treatment for acute decompensated heart failure. By placing the device on the patient's chest, it collects data on cardiac output and intracardiac pressures, which are crucial for predicting patient outcomes. The goal is to determine the feasibility of using this device to identify patients at risk of deterioration and to assess which data points best predict survival and major adverse cardiac events. This approach aims to provide a quick, easy-to-use monitoring tool that can be utilized by healthcare practitioners or patients themselves.

Why it matters

Potential benefit: If successful, this study could lead to improved monitoring and management of heart failure patients, potentially reducing hospital readmissions and improving survival rates.

How similar studies have gone: While similar studies have explored non-invasive monitoring techniques, the specific use of the Acorai device in this context is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: Subjects must meet all the following criteria to be eligible for participation in the clinical investigation

1. Subjects medically fit for discharge following an admission to Hospital with decompensated heart failure requiring intravenous diuretic therapy
2. Subject is willing and physically able to comply with the specified evaluations as per clinical investigation plan, as assessed by the investigator.
3. Subject is able to provide written consent to participate in the study

Exclusion Criteria:

1. Pregnancy
2. Discretionary exclusion when, in the opinion of the investigator, the inclusion of a potential subject is not in their best interest or not in the interest of compliant performance of the clinical trial

Where it's running

  • Harefield Hospital
    Uxbridge, Middlesex, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.